Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

21 selected members of the ASTRO will be honoured at the ASTRO 2011, 53rd Annual Meeting in October 2-6, 2011 at the Miami Beach Convention Center in Miami Beach, Fla.

The American Society for Radiation Oncology (ASTRO) has named its 2011 class of Fellows. These 21 distinguished members will receive their Fellow designation at a ceremony during the Society's 53rd Annual Meeting being held October 2-6, 2011, at the Miami Beach Convention Center in Miami Beach, Fla.

"ASTRO Fellows are some of the most revered and accomplished members of the radiation oncology community and receiving this distinction is a great honor for them," Leonard Gunderson, MD, MS, FASTRO, ASTRO President and Emeritus Professor and Consultant in Radiation Oncology at the Mayo Clinic in Arizona, said. "Congratulations to this year's class."

Members of ASTRO are eligible to become a Fellow if they have been part of the Society for at least 15 years, have given significant service to ASTRO and have made a significant contribution to the field of radiation oncology. The primary pathways to becoming a Fellow are excellence in research, patient care, education and leadership/service. The Society values contributions to all four areas; however, each nominee needed to have a truly outstanding contribution to at least one of the pathways to be named a Fellow.

See more about our conference news

The nominations were reviewed by the nine-member Fellows Selection Committee who made recommendations to the ASTRO Board of Directors.

This year's Fellows class includes:

• James A. Bonner, MD, University of Alabama Comprehensive Cancer Center, Birmingham, Ala.
• David M. Brizel, MD, Duke University Medical Center, Durham, N.C.
• Indra. J. Das, PhD, Indiana University School of Medicine, Indianapolis
• Anthony. V. D'Amico, MD, PhD, Brigham and Women's Hospital, Boston
• Chul Soo Ha, MD, University of Texas Health Science Center, San Antonio
• Paul M. Harari, MD, University of Wisconsin, Department of Human Oncology, Madison, Wis.
• Michael R. Kuettel, MD, PhD, Roswell Park Cancer Institute, Buffalo, N.Y.
• Nina A. Mayr, MD, The Ohio State University, The James Cancer Hospital, Columbus, Ohio
• Jeff M. Michalski, MD, Washington University School of Medicine, St. Louis
• Radhe Mohan, PhD, MD Anderson Cancer Center, Houston
• Daniel G. Petereit, MD, John. T. Vucurevich Regional Cancer Center Institute, Rapid City, S.D.
• Louis Potters, MD, North Shore – LIJ Health System, Hyde Park, N.Y.
• William Small Jr. MD, Northwestern Memorial Hospital, Chicago
• Luis Souhami, MD, McGill University, Montreal, Quebec, Canada
• Baldassarre Stea, MD, PhD, University of Arizona College of Medicine, Tucson, Ariz.
• Nancy J. Tarbell, MD, Harvard Medical School, Boston
• David E. Wazer, MD, Tufts Medical Center, Boston
• Christopher G. Willett, MD, Duke University Medical Center, Durham, N.C.
• Jacqueline P. Williams, PhD, University of Rochester, Rochester, N.Y.
• Lynn D. Wilson, MD, MPH, Yale School of Medicine, New Haven, Conn.
• Anthony L. Zietman, MD, Massachusetts General Hospital, Boston

Source: ASTRO